These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 8153675

  • 21. [Recombinant human erythropoietin in the treatment of anemic patients undergoing chemotherapy for cancer].
    Bösze P, Mayer A, Thurzó L, Kiss A, Rák K, Stumpf J.
    Orv Hetil; 1995 Nov 19; 136(47):2567-72. PubMed ID: 8532322
    [Abstract] [Full Text] [Related]

  • 22. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD, James KM, Levy JK, Browne JK, Miller A, Lobingier RT, Egrie JC.
    J Am Vet Med Assoc; 1998 Feb 15; 212(4):521-8. PubMed ID: 9491159
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Human recombinant erythropoietin in the treatment of the anemia of multiple myeloma].
    Valladares Ayerbes MJ, Valenzuela Claros JC, Reina Zoilo JJ, Ruiz Borrego M, Moreno Nogueira JA.
    An Med Interna; 1997 Nov 15; 14(11):593-4. PubMed ID: 9445590
    [No Abstract] [Full Text] [Related]

  • 26. Treatment of renal anemia by erythropoietin substitution. The effects on the cardiovascular system.
    Radermacher J, Koch KM.
    Clin Nephrol; 1995 Nov 15; 44 Suppl 1():S56-60. PubMed ID: 8608665
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Anemia in multiple myeloma.
    Ludwig H, Pohl G, Osterborg A.
    Clin Adv Hematol Oncol; 2004 Apr 15; 2(4):233-41. PubMed ID: 16163188
    [Abstract] [Full Text] [Related]

  • 30. [Erythropoietin treatment of anemia associated with multiple myeloma (MM) and myelodysplastic syndrome (MDS)].
    Qiao ZH.
    Zhonghua Zhong Liu Za Zhi; 1993 Mar 15; 15(2):122-4. PubMed ID: 8223121
    [Abstract] [Full Text] [Related]

  • 31. Therapy of anemia in patients with multiple myeloma.
    Adam Z, Krahulová M, Spelda S, Vorlícek J, Hejlová N, Hájek R, Tomíska M.
    Acta Med Austriaca; 1995 Mar 15; 22(4):59-64. PubMed ID: 8835422
    [Abstract] [Full Text] [Related]

  • 32. Safety and efficacy of recombinant human erythropoietin treatment of anaemia associated with multiple myeloma in haemodialysed patients.
    Ruedin P, Pechère Bertschi A, Chapuis B, Benedet P, Leski M.
    Nephrol Dial Transplant; 1993 Mar 15; 8(4):315-8. PubMed ID: 8390005
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Use of erythropoietin in patients with multiple myeloma.
    Egerer G, Harter C, Karthaus M, Ho AD, Goldschmidt H.
    Onkologie; 2003 Feb 15; 26(1):80-4. PubMed ID: 12624523
    [Abstract] [Full Text] [Related]

  • 35. Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r-HuEPO).
    Roger SD, Baker LR, Raine AE.
    Clin Nephrol; 1993 Feb 15; 39(2):103-10. PubMed ID: 8448912
    [Abstract] [Full Text] [Related]

  • 36. Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia.
    Mittelman M, Zeidman A, Fradin Z, Magazanik A, Lewinski UH, Cohen A.
    Acta Haematol; 1997 Feb 15; 98(4):204-10. PubMed ID: 9401498
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Human immunodeficiency virus infection, anemia, and survival.
    Moore RD.
    Clin Infect Dis; 1999 Jul 15; 29(1):44-9. PubMed ID: 10433563
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.